Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Agomab Therapeutics to Acquire Origo Biopharma
Friday, October 29, 2021Agomab Therapeutics NV announced that it has entered into a definitive agreement under which it will acquire Origo Biopharma SL a Spanish clinicalstage biotechnology company developing organrestricted small molecule drug candidates targeting the tran...
XtalPi and Signet Expand AI Drug Discovery Collaboration to Novel Cancer Target
Thursday, October 28, 2021Signet Therapeutics and XtalPi Inc a physicsbased AIpowered drug RD company announced the expansion of their AI drug discovery collaboration to include a new firstinclass program against a novel cancer target identified by Signet The two companies en...
WuXi Biologics Completes GMP Inspection by Health Canada for Drug Substance Facility
Thursday, October 28, 2021WuXi Biologics a global company with leading openaccess biologics technology platforms announced that it has completed a remote GMP inspection by Health Canada for its drug substance facility MFG in Wuxi city There were no observations during the ins...
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
Wednesday, October 27, 2021Teva Pharmaceutical Industries Ltd and MODAG GmbH today announced a strategic collaboration on the exclusive worldwide licensing and development of MODAGs lead compound anleb and a related compound sery Anleb targets pathological alphasynuclein oligo...
Boehringer Ingelheim Partners with Thoeris to Investigate a Novel Approach to Treat Urea Cycle Disorders
Wednesday, October 27, 2021Boehringer Ingelheim and Thoeris GmbH announce a collaboration and license agreement with the aim to investigate novel firstinclass therapies for patients with urea cycle disorders UCDs UCDs are rare diseases caused by genetic liver dysfunctions lead...
Xeris Pharmaceuticals Enters Collaboration Agreement With Merck
Tuesday, October 26, 2021Xeris Biopharma Holdings Inc a biopharmaceutical company developing and commercializing unique therapies for patient populations in endocrinology neurology and gastroenterology today announced a collaboration agreement with Merck with an option to l...
Tremeau Expands Pipeline with Novel Non-Opioid Compound for the Treatment of Acute Pain
Tuesday, October 26, 2021Tremeau Pharmaceuticals today announced that the US Patent and Trademark Office USPTO has issued a Notice of Allowance for US Patent Application No Once issued the patent will provide composition of matter patent protection for Tremeaus novel deuter...
FDA Approves Genentech’s Susvimo, a First-of-Its-Kind Therapeutic Approach for Wet Age-Related Macular Degeneration (AMD)
Monday, October 25, 2021Genentech a member of the Roche Group announced that the US Food and Drug Administration FDA has approved Susvimo ranibizumab injection mgmL for intravitreal use via ocular implant for the treatment of people with wet or neovascular agerelated macul...
Oncodesign and TiumBio Sign Collaboration Agreement for R&D of Fibrosis Drug Candidates
Friday, October 22, 2021Oncodesign a French biopharmaceutical company specialized in kinase inhibitor research and precision medicine and TiumBio a company specializing in RD for rare diseases have announced the signature of a research collaboration agreement on RD of poten...
Mablink Bioscience and Emergence Therapeutics Enter Into a Licensing Agreement to Develop Antibody Drug Conjugate as a Potential Cancer Therapy
Friday, October 22, 2021Mablink Bioscience SAS a biotechnology company developing a pipeline of ADC based on its proprietary PSARlink druglinker technology and Emergence Therapeutics AG a European biopharmaceutical company developing novel antibody drug conjugate ADC immuno...
